vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Verisign (VRSN). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $425.3M, roughly 1.2× Verisign). Verisign runs the higher net margin — 48.5% vs 6.8%, a 41.7% gap on every dollar of revenue. On growth, Verisign posted the faster year-over-year revenue change (7.6% vs -1.7%). Over the past eight quarters, Verisign's revenue compounded faster (5.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.
MD vs VRSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $425.3M |
| Net Profit | $33.7M | $206.2M |
| Gross Margin | — | 88.5% |
| Operating Margin | 9.9% | 67.0% |
| Net Margin | 6.8% | 48.5% |
| Revenue YoY | -1.7% | 7.6% |
| Net Profit YoY | 10.5% | 7.7% |
| EPS (diluted) | $0.40 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $425.3M | ||
| Q3 25 | $492.9M | $419.1M | ||
| Q2 25 | $468.8M | $409.9M | ||
| Q1 25 | $458.4M | $402.3M | ||
| Q4 24 | $502.4M | $395.4M | ||
| Q3 24 | $511.2M | $390.6M | ||
| Q2 24 | $504.3M | $387.1M | ||
| Q1 24 | $495.1M | $384.3M |
| Q4 25 | $33.7M | $206.2M | ||
| Q3 25 | $71.7M | $212.8M | ||
| Q2 25 | $39.3M | $207.4M | ||
| Q1 25 | $20.7M | $199.3M | ||
| Q4 24 | $30.5M | $191.5M | ||
| Q3 24 | $19.4M | $201.3M | ||
| Q2 24 | $-153.0M | $198.8M | ||
| Q1 24 | $4.0M | $194.1M |
| Q4 25 | — | 88.5% | ||
| Q3 25 | — | 88.4% | ||
| Q2 25 | — | 88.0% | ||
| Q1 25 | — | 87.7% | ||
| Q4 24 | — | 87.8% | ||
| Q3 24 | — | 88.0% | ||
| Q2 24 | — | 87.8% | ||
| Q1 24 | — | 87.2% |
| Q4 25 | 9.9% | 67.0% | ||
| Q3 25 | 13.8% | 67.8% | ||
| Q2 25 | 12.8% | 68.5% | ||
| Q1 25 | 7.0% | 67.4% | ||
| Q4 24 | 7.8% | 66.7% | ||
| Q3 24 | 6.6% | 68.9% | ||
| Q2 24 | -31.3% | 68.8% | ||
| Q1 24 | 3.2% | 67.4% |
| Q4 25 | 6.8% | 48.5% | ||
| Q3 25 | 14.5% | 50.8% | ||
| Q2 25 | 8.4% | 50.6% | ||
| Q1 25 | 4.5% | 49.5% | ||
| Q4 24 | 6.1% | 48.4% | ||
| Q3 24 | 3.8% | 51.5% | ||
| Q2 24 | -30.3% | 51.4% | ||
| Q1 24 | 0.8% | 50.5% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | — | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $580.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $-2.2B |
| Total Assets | $2.2B | $1.3B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $580.5M | ||
| Q3 25 | $340.1M | $617.7M | ||
| Q2 25 | $224.7M | $593.8M | ||
| Q1 25 | $99.0M | $648.5M | ||
| Q4 24 | $229.9M | $599.9M | ||
| Q3 24 | $103.8M | $644.9M | ||
| Q2 24 | $19.4M | $689.9M | ||
| Q1 24 | $8.0M | $924.7M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $-2.2B | ||
| Q3 25 | $890.7M | $-2.1B | ||
| Q2 25 | $833.8M | $-2.0B | ||
| Q1 25 | $789.2M | $-2.0B | ||
| Q4 24 | $764.9M | $-2.0B | ||
| Q3 24 | $732.5M | $-1.9B | ||
| Q2 24 | $706.5M | $-1.8B | ||
| Q1 24 | $856.2M | $-1.6B |
| Q4 25 | $2.2B | $1.3B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.4B | ||
| Q1 25 | $2.0B | $1.4B | ||
| Q4 24 | $2.2B | $1.4B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $2.0B | $1.5B | ||
| Q1 24 | $2.2B | $1.7B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $289.6M |
| Free Cash FlowOCF − Capex | — | $285.1M |
| FCF MarginFCF / Revenue | — | 67.0% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $289.6M | ||
| Q3 25 | $137.3M | $307.7M | ||
| Q2 25 | $137.2M | $202.5M | ||
| Q1 25 | $-117.5M | $291.3M | ||
| Q4 24 | $133.0M | $231.5M | ||
| Q3 24 | $91.8M | $253.4M | ||
| Q2 24 | $107.0M | $160.4M | ||
| Q1 24 | $-125.2M | $257.3M |
| Q4 25 | — | $285.1M | ||
| Q3 25 | — | $303.0M | ||
| Q2 25 | — | $194.7M | ||
| Q1 25 | — | $285.5M | ||
| Q4 24 | — | $222.0M | ||
| Q3 24 | — | $247.8M | ||
| Q2 24 | — | $151.2M | ||
| Q1 24 | — | $253.5M |
| Q4 25 | — | 67.0% | ||
| Q3 25 | — | 72.3% | ||
| Q2 25 | — | 47.5% | ||
| Q1 25 | — | 71.0% | ||
| Q4 24 | — | 56.1% | ||
| Q3 24 | — | 63.4% | ||
| Q2 24 | — | 39.1% | ||
| Q1 24 | — | 66.0% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 3.39× | 1.40× | ||
| Q3 25 | 1.91× | 1.45× | ||
| Q2 25 | 3.49× | 0.98× | ||
| Q1 25 | -5.66× | 1.46× | ||
| Q4 24 | 4.36× | 1.21× | ||
| Q3 24 | 4.72× | 1.26× | ||
| Q2 24 | — | 0.81× | ||
| Q1 24 | -31.03× | 1.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
VRSN
Segment breakdown not available.
